HCA Healthcare forecasts upbeat 2025 profit on strong medical care demand

Go back to HCA Healthcare forecasts upbeat 2025 profit on strong medical care demand

Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)

January 27, 2025 11:46 AM EST

Mizuho analyst Ann Hynes reiterated an Outperform rating and $425.00 price target on HCA Healthcare Inc (NYSE: HCA).

The analyst comments "We are maintaining our price target of $425, and our 2025E-2026E adjusted EBITDA estimates, while increasing our 2025E-2026E adjusted EPS estimates driven by... More

HCA Healthcare Inc (HCA) PT Lowered to $404 at Leerink Partners

January 27, 2025 6:23 AM EST

Leerink Partners analyst Whit Mayo lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $404.00 (from $460.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: Reiterate Outperform rating. 4Q24 results brought forth a continuation of strong demand trends, good cost controls and... More